Skip to main content
logo
Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
52.10
-1.78 (-3.30%)
Aug 14, 2025, 12:03 PM - Market open

Haemonetics Revenue

Haemonetics had revenue of $321.39M in the quarter ending June 28, 2025, a decrease of -4.40%. This brings the company's revenue in the last twelve months to $1.35B, up 0.91% year-over-year. In the fiscal year ending March 29, 2025, Haemonetics had annual revenue of $1.36B with 3.95% growth.

Revenue (ttm)
$1.35B
Revenue Growth
+0.91%
P/S Ratio
1.99
Revenue / Employee
$445,268
Employees
3,023
Market Cap
2.51B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 29, 20251.36B51.77M3.95%
Mar 30, 20241.31B140.40M12.01%
Apr 1, 20231.17B175.46M17.67%
Apr 2, 2022993.20M122.73M14.10%
Apr 3, 2021870.46M-118.02M-11.94%
Mar 28, 2020 Pro Pro Pro
Mar 30, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Apr 1, 2017 Pro Pro Pro
Apr 2, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

HAE News

More News